| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 846.73 | 0.2% | 11.7% |
| Total Income | 877.98 | 0.5% | 11.3% |
| Expenditure | 739.85 | 0.3% | 13.0% |
| PBT | 138.14 | 2.0% | 3.0% |
| Net Profit | 103.75 | 1.9% | 1.8% |
| OPM | 19.80% | 0.14pp | 0.45pp |
| NPM | 11.82% | 0.16pp | 1.10pp |
| EPS | 7.47 | 1.8% | 0.9% |
Strong margin, flat growth; MSOCK bet could reshape margins by FY28
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit Q2 PAT guidance (+104 Cr vs stated), maintained EBITDA >20%, confirmed ₹900 Cr quarterly aspirational. But sequential revenue growth is 0.2%, signaling deal pipeline is not flowing evenly.
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Q2 revenue growth has stalled (0.2% QoQ, 11.7% YoY vs 17% LTM), but MSOCK investment and explicit ₹4,000 Cr FY28 target offer multi-year upside if execution delivers. Margin expansion story credible if costs stay flat and deals close. Key risk: quarterly stagnation, MSOCK monetization timeline uncertain.
₹846.7 Cr
Revenue · +11.7% YoY₹103.8 Cr
Reported PAT · +1.8% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
PAT stood at ₹104 crore in Q2
METDelivered PAT ₹103.8 Cr; variance <0.2%
EBITDA margin at 22.7% in Q2
METQ2 EBITDA ₹199 Cr on ₹878 Cr total income = 22.7%; OPM 19.8% on ₹846.7 Cr operational revenue
Confident of ₹900 crore quarterly revenue in next 2Q
METCurrent Q2 ₹846.7 Cr; would require +6.3% QoQ growth; prior Q3/Q4 were ₹720/₹850, so feasible but dependent on deal closures
Cost base flat at ₹680 crore, will remain ₹680-700 Cr
METQ2 costs stated ₹680 Cr; flat vs Q1 despite 0.2% QoQ revenue growth shows margin expansion potential if revenue accelerates
17% LTM revenue growth achieved
METLTM revenue ₹3,388 Cr; YoY growth 17%; matches 20% ±2-3% guidance on LTM basis
Platform revenue up 51%, license-linked up 18%
METPlatform ₹591 Cr from ₹392 Cr = 51% growth; license-linked ₹1,768 Cr from ₹1,497 Cr = 18% growth; both segments growing faster than consolidated
Earnings quality
What changed since the last call
FY28 guidance quantified
UpgradePrior: aspirational ₹900 Cr quarterly. Now: explicit ₹4,000 Cr FY28 target (4.7x from Q2). Raises bar but shows conviction.
MSOCK moved from concept to live
UpgradeQ1 → Q2: 141 projects live (vs 16 in Q1), 39 patents filed, 25 institutions gone live. Early monetization beginning.
Central 1 customer term expired
DowngradePlatform revenue hit by ~80% retention loss on Central 1 contract; 20% churn expected. Partially offset by new deals.
Cost discipline maintained
NeutralCosts stayed ₹680 Cr Q1→Q2 despite +0.2% revenue growth. Management committed to ₹680-700 Cr range going forward.
Margin expansion narrative shifted
NeutralPrior: margin expansion via cost reduction. Now: margin expansion via deal values rising (subscription-linked), cost flat. Requires revenue growth to materialize.
The Q&A
Analysts pressed hard on margin trajectory (Prolin, Rohit), MSOCK monetization timing (Vivek, Ravi), and growth acceleration (all). Management held firm on ₹4,000 Cr FY28 but admitted timing uncertain; offered cost stability as confidence signal.
Revenue recognition models — Adi Jhawar, AK Investment
AnsweredA1: Licence revenue recognised upfront. A2: Implementation (includes customisation) recognised as work completes. A3: AMC recognised over service life. Customisation = 48% of implementation revenue.
R&D capitalisation & margin inflation — Dev Mehta, Unique PMS
AnsweredQ2: ₹54 Cr expensed, ₹42-43 Cr capitalised. LTM: ₹230 Cr expensed, ₹170 Cr capitalised. FY27 is inflection if MSOCK wins drive margin lift.
MSOCK growth & deal acceptance — Vivek Taruga, Prop Tree Asset Management
Partial20% growth is company calibration. MSOCK is not about 1% margin; it's about mainframe-to-cloud shift. Competitor set is CAST, Palantir (defense), not Oracle.
Margin expansion sustainability — Prolin Nandu, Edelweiss Public Alternatives
PartialCosts invested (₹100 Cr in AI) now; revenue upside comes later. MSOCK + Purple Fabric scaling will drive leverage. Margins at 20% now, will improve as revenue scales.
Competitive moat & product risk — Dhruesh Sanghvi, Prop Tree
AnsweredService company can't build products with 800-900 microservices issues. MSOCK is different—it's knowledge management, not code. We showed 12-month project delivered in 8 months.
Buyback vs acquisitions — Paresh Sangani, Club Millionaire
AnsweredMSOCK opportunity is bigger. Acquisition strategy: targeting 3-4 acquisitions of specific size, focused on market access. Will revisit buyback when MSOCK matures.
Central 1 customer loss impact — Mayank Babla, Carnelian Capital
PartialQ2: specific impact TBD. Q3 estimate: 300k-400k USD. Timing of next vendor's platform readiness uncertain (3Q+ cycle).
MSOCK go-to-market & monetization — Ravi Mehta, OneUp
AnsweredMSOCK will be a separate product line. Using it for internal operations (141 projects) builds trust. Purple Fabric & MSOCK can go independently; subscription model.
MSOCK vs EKG heritage — Rishabh Aggarwal, Suraag Capital
AnsweredMSOCK is next-gen knowledge management (39 patents). Uses 30% frontier model, 70% proprietary. EKG was vectorisation; MSOCK is multi-dimensional, multi-layer connected knowledge.
Margin progression on rising deal values — Rohit Balakrishnan, SG
AnsweredCurrent EBITDA 27%, cost base ₹680-700 Cr. At ₹850 Cr revenue: 27% margin. At ₹950 Cr: 30%. At ₹1,000+ Cr: 30%+ (Temenos-like levels).
Guidance
FY28 revenue target ₹4,000 Cr (explicit)
Medium4.7x from Q2 ₹846.7 Cr; requires ~20% CAGR FY27-28. Dependent on MSOCK & deal velocity.
Quarterly run-rate ₹900+ Cr in next 2 quarters
MediumFrom ₹846.7 Cr Q2; +6% growth needed by Q4. Prior Q4 was ₹850 Cr, so achievable if deals close.
LTM growth 20% ±2-3% basis maintained
HighCurrently 17% LTM; on track to hit 20% range by FY27 end if YoY growth sustains.
EBITDA margin >20% full year maintained
HighQ2 EBITDA 22.7%; LTM 21.7%. Comfortable above 20% threshold.
Margin expansion to 27-30% by FY28 implied
MediumManagement indicated path: ₹950 Cr revenue @ ₹680-700 Cr cost = 27%; ₹1,000+ Cr = 30%.
R&D investment continued at ₹170+ Cr/quarter capitalised
HighLTM ₹170 Cr capitalised; ₹230 Cr expensed. MSOCK is ongoing CapEx, not declining.
Risks the call surfaced
MSOCK monetization timing
High141 projects live but no material revenue impact quantified. Mainframe-to-cloud deals take 12-24 months to close; FY28 ₹4,000 Cr target depends on this.
Central 1 customer loss
MediumCentral 1 customer migration away after 80% contract term expired; management expected 20% churn. Other 2-3 customers also lost in Q2. Platform revenue growth of 51% masked by this loss.
Quarterly revenue growth stagnation
MediumQ2 revenue ₹846.7 Cr vs Q1 ~₹845 Cr = +0.2% QoQ growth. Despite ₹13,125 Cr pipeline, closes are uneven. Sequential stagnation raises questions about deal conversion speed.
Margin expansion delayed by cost base
MediumCosts held flat at ₹680 Cr Q1-Q2 despite ₹100+ Cr annual R&D investment in MSOCK. No operating leverage yet. If revenue growth continues to be 0.2% QoQ, margin expansion will stall.
FY28 ₹4,000 Cr target execution risk
High₹4,000 Cr FY28 revenue = 4.7x Q2; requires 20%+ CAGR. Currently at 17% LTM growth. MSOCK must unlock new deals, macro must remain stable, deal wins must accelerate.
Management
Score 7/10. Clear and articulate on business model, deal strategy, and MSOCK positioning. Deflected on precise MSOCK monetization timing. Candid on customer losses and cost structure. Track record mixed: hit PAT targets, maintained ±20% LTM growth, but quarterly stagnation (0.2% QoQ) suggests deal timing volatility. MSOCK execution early (141 projects live) but revenue impact unquantified.
1 · Q3 FY27
Central 1 customer impact quantified; next deal closures signaled
2 · Q4 FY27
Path to ₹900 Cr+ quarterly becomes visible or revised
3 · FY28 H1
MSOCK wins & deals announced; mainframe-to-cloud migration deals close
Key risk: quarterly stagnation, MSOCK monetization timeline uncertain.
Strong margins mask flat quarterly growth — the MSOCK bet is long-dated
Intellect delivered robust EBITDA margins (22.7%) and maintained guidance, but sequential revenue barely moved (±0.2% QoQ). The ₹4,000 Cr FY28 target hinges on deal closures accelerating, not on execution to date.
₹846.7 Cr
+11.7% YoY, +0.2% QoQ
₹103.8 Cr
+1.8% YoY, +1.9% QoQ
22.7%
vs 21.7% LTM; above 20% guidance
17%
tracking 20% ± 2–3% guidance
Year-over-year, Intellect's Q2 result looks solid: revenue up 11.7%, margin at 22.7%, guidance confirmed. But sequence the quarters, and the tension becomes clear. Q2 revenue of ₹846.7 Cr grew a mere ₹1.7 Cr from Q1 (0.2% QoQ). PAT, at ₹103.8 Cr, showed only ₹1.9 Cr growth. Management credits a ₹13,125 Cr deal pipeline and flagged 21 wins in Q2 — the highest quarterly count — yet closures were lumpy enough to leave sequential momentum at near-zero.
The margin is real; the operating leverage is deferred
EBITDA came in at 22.7% (₹199 Cr on ₹878 Cr total income), comfortably above the >20% full-year guidance and above the 21.7% LTM run-rate. That's genuine pricing power and deal quality — the company is not cutting rates to win. What's absent is the operating leverage story. Costs held flat at ₹680 Cr in both Q1 and Q2, despite the company pouring ₹100+ Cr annually into MSOCK R&D. Management explicitly committed to keeping costs in the ₹680–700 Cr range through FY27, signalling discipline but also acknowledging that margin expansion depends entirely on revenue acceleration, not on leverage.
The path management outlined is clear: at ₹850 Cr quarterly revenue with ₹680–700 Cr costs, EBITDA margin would be 27%; at ₹950 Cr, 30%; at ₹1,000+ Cr, 30%+. Temenos-like territory. But that requires growth to re-accelerate from the current 0.2% QoQ. If Q3 and Q4 repeat Q2's stagnation, the margin upside stays theoretical.
Claims on the call vs. what held up
PAT at ₹104 Cr in Q2
EBITDA margin 22.7%
Platform revenue up 51% to ₹591 Cr
License-linked revenue up 18% to ₹1,768 Cr
MSOCK deployed across 141 projects, 39 patents, 25 institutions live
Cost base flat at ₹680 Cr despite 0.2% revenue growth
LTM growth 17%, tracking 20% ± 2–3% guidance
Confident of ₹900 Cr quarterly revenue in next 2 quarters
Every major claim reconciled with the delivered numbers. The tension isn't in earnings quality — it's in timing. Intellect has hit its stated PAT target, maintained EBITDA >20%, and built a 141-project proof-of-concept for MSOCK. But the market is asking: when does this translate to 6% quarterly growth (needed to hit ₹900 Cr in Q3–Q4) and then 20% CAGR to ₹4,000 Cr in FY28?
What changed on this call
FY28 revenue target quantified to ₹4,000 Cr. Prior guidance was aspirational (₹900 Cr quarterly). Now it's explicit — a 4.7× jump from Q2's ₹846.7 Cr run-rate, requiring 20% CAGR through FY28. That's conviction, but it's also a step-change claim: the deal pipeline must convert, MSOCK must unlock new logos, and macro must cooperate.
MSOCK moved from lab to live customer deployments. Q1 saw 16 projects; Q2 jumped to 141. Thirty-nine patents filed. Twenty-five institutions deployed. Early delivery accelerations reported (12-month projects delivered in 8 months). But: no quantified revenue impact yet. The call acknowledged 7 of 21 Q2 wins were AI-led (33%), but the revenue contribution from MSOCK itself is not separated.
Central 1 customer loss quantified. A material UK credit-union platform customer migrated away after 80% of contract term expired. Expected 20% churn on the rest. Management expects Q3 impact of ₹30–40 lakh USD (~₹2.5–3.3 Cr annual run-rate). Platform revenue grew 51% YoY, but this loss is a headwind against the headline.
Cost commitment to ₹680–700 Cr/quarter affirmed. Management is signalling cost discipline and confidence that operating leverage will emerge if revenue scales, not through cost cuts.
The bull-bear ledger
Deal pipeline at all-time high (₹13,125 Cr, 103 destiny deals); 21 Q2 wins, highest quarterly count
EBITDA margin 22.7%, room to expand to 27–30% at ₹950 Cr+ quarterly revenue
License-linked revenue (52% of total) up 18%, subscription upside with multi-year contracts
MSOCK delivers early (8-month vs. 12-month baseline); 39 patents; 141 projects live
Gross margin 57.2%, no pricing pressure despite high-value platform deals
Sequential growth is 0.2% — effectively flat; lumpiness masks underlying momentum
PAT growth 1.8% YoY — nearly stalled; leverage not yet emerging
FY28 target is 4.7× current run-rate; 20% CAGR dependent on deal velocity, not demonstrated yet
MSOCK monetization path vague; 141 projects live but revenue impact unquantified
Central 1 loss and 2–3 other customer churn in Q2; platform segment headwind emerging
Risks, ranked by how much they should concern a holder
FY28 ₹4,000 Cr target execution risk
HighRequires 20% CAGR from current ₹846.7 Cr quarterly run-rate. MSOCK is central to the case, but monetization timeline is unquantified. If deal velocity doesn't accelerate Q3–Q4, the ₹4,000 Cr target becomes unachievable.
MSOCK monetization timing and revenue ramp
High141 projects live and 39 patents show capability, but no material revenue contribution quantified. Mainframe-to-cloud deals take 12–24 months to close. If MSOCK fails to unlock new logos or delays its go-to-market, FY28 growth targets will stall.
Quarterly revenue growth stagnation (0.2% QoQ)
MediumPipeline is strong (₹13,125 Cr) but deal closures are lumpy. If Q3–Q4 repeat Q2's near-zero growth, management's ₹900 Cr quarterly aspirational will miss, and ₹4,000 Cr FY28 becomes a stretch.
Central 1 customer loss and platform concentration
MediumPlatform revenue grew 51% but this large loss offsets gains. Other 2–3 customer churn also reported Q2. If platform segment continues to lose large customers, the fastest-growing segment becomes a drag.
Operating leverage deferred by flat cost base
MediumCosts held flat at ₹680 Cr despite 0.2% revenue growth. If growth doesn't accelerate, margin expansion to 27–30% will not materialize. Current 22.7% is strong but not exceptional for a software/services company.
Competitive response and deal-win rate pressure
LowOracle, Temenos, and other large players may accelerate AI offerings and pricing. Intellect's ₹13,125 Cr pipeline gives confidence, but a single macro slowdown or competitor win could stall closes.
How the street is positioning
The stock sits at ₹534.65, down 57.4% from its all-time high of ₹1,255. It is trading below its 20-day, 50-day, and 200-day moving averages (₹586.72, ₹628.76, ₹705.66, respectively). RSI is 37.2 (neutral zone). The 52-week range is ₹478–₹1,244.6; at current levels, the stock is 11.85% above the low but more than halfway down from the ATH.
Ownership has shifted. FII ownership in Q1 FY27 (most recent filing) is 23.51%, down from 25.57% in Q4 FY26 — a two-percentage-point decline in two quarters. This is a trim, not a rout, but it signals that foreign investors are cautious. DII ownership is stable at 7.33% (up slightly from 7.10% Q4). Promoter holdings are flat at 29.62%.
The stock's drawdown and FII trimming stand in contrast to the fundamental story. Management is guiding to ₹4,000 Cr (FY28), the deal pipeline is at an all-time high, and MSOCK is now in 141 live projects. Yet the market is pricing in risk — specifically, execution risk and monetization uncertainty. The Q2 result (11.7% YoY growth, +0.2% QoQ) did not move the needle; sequential stagnation is the market's read on whether Intellect can sustain the growth narrative to ₹4,000 Cr.
The debate
What to watch next
1 · Q3 sequential growth and deal closures
Management guided to ₹900 Cr quarterly in the next 2 quarters. Q3 will show whether the ₹13,125 Cr pipeline is converting at pace or remaining theoretical. >5% QoQ growth (₹889 Cr+) is the bar to clear skepticism.
2 · MSOCK monetization and new logo wins
The call mentioned 141 projects live and early delivery wins (12→8 months). Q3 will show: are new customer logos choosing Intellect because of MSOCK? Is there a separate revenue line forming? Or is MSOCK still an internal efficiency play?
3 · Central 1 impact quantified and platform stabilization
Management estimated Q3 impact at ₹30–40 lakh USD. If platform revenue declines more than expected or other large customers churn, the 51% YoY growth narrative breaks. Watch for platform segment revenue in Q3 vs. Q2 (₹591 Cr baseline).
4 · Cost base discipline maintained
If costs stay in the ₹680–700 Cr range and revenue reaches ₹900 Cr, EBITDA margin will prove the path to 27%+. If costs creep or revenue misses ₹900 Cr, margin upside will stall and confidence in the FY28 target will crack.
Management's tone on the call was confident and articulate on MSOCK and the FY28 vision, but notably hedged on near-term acceleration. Analysts pushed hard on margin trajectory (Prolin Nandu, Rohit Balakrishnan) and MSOCK monetization timing (Vivek Taruga, Ravi Mehta); management held firm on the ₹4,000 Cr target but admitted timing uncertainty. That honesty is credible but also a red flag: the street is not convinced the growth inflection is here.
The single number to track
Intellect's Q2 result is a study in contrast: margin is strong (22.7%), but sequential growth is flat (0.2% QoQ). Management has built real assets (MSOCK, ₹13,125 Cr pipeline, 21 Q2 wins) and is explicit on the ₹4,000 Cr FY28 target. Yet the stock is down 57%, FII is trimming, and the market is pricing in execution risk.
This is not a step-change quarter. It's a steady-execution quarter with outsized optionality attached. Margin is real; growth inflection is promised but not yet delivered.
The number to track from here: quarterly revenue growth rate. Q3 will show whether Intellect can accelerate from 0.2% QoQ to the 5–6% needed to hit ₹900 Cr. That's the gate to ₹4,000 Cr credibility and a re-rating of the stock. Until then, Hold is the right posture — own the margin, wait for growth proof.
Can Intellect Sustain 20% Growth as AI Momentum Meets Valuation Reset?
After Q1's 19% YoY jump to ₹872 Cr, Intellect reports Q2 with a key test: whether platform velocity (Jameel Finance, Cargills Bank, UAE partnerships) translates to sustained revenue momentum and margin stability in a stock already down 54% from peak.
The Number That Matters: Sustaining 20%+ LTM Growth at Rising Scale
Intellect's core promise to the Street is 20% LTM revenue growth with 22–25% EBITDA margins by FY28. Q1 FY27 delivered ₹872 Cr (19% YoY), and the company is tracking a ₹4,000 Cr / ₹1,000 Cr EBITDA target by FY28. In Q2, the Street will be watching whether platform monetization (the AI-first eMACH.ai wins announced post-Q1—Jameel Finance Egypt, Cargills Bank Sri Lanka, UAE bank deal) translates to sequential momentum and whether margins hold amid a cost headwind from R&D and go-to-market spend on these newer verticals.
~₹880–900 Cr
Implies 16–18% YoY growth, inline with prior 19% (Q1) as comps harden; LTM would hold ~21%
~23–24%
In-line with FY27 guidance; Q1 delivered ₹194 Cr EBITDA (22.3% margin)
~₹70–75 Cr
Tax-normalized; track margin expansion vs. one-time adjustments
~50%+ of total
Key recurring-revenue stream; in Q1 grew 17% YoY to ₹457 Cr
What a strong quarter looks like: Revenue ₹910+ Cr with 23%+ EBITDA margin; licensing growth 18%+; management reiterating 20% LTM growth for FY27 and raising FY28 guidance. Margin commentary should stress investment in go-to-market (sales/presales for new eMACH verticals) as temporary headwind—not structural. What a weak quarter looks like: Revenue misses ₹880 Cr (sub-16% YoY) or margins slip to 21% (cost overrun signal); any revision to FY27/28 guidance; or Q2 deal-win velocity slower than Q1.
On Track? Trajectory Through FY27
Q1 FY27 showed 19% YoY revenue growth, bringing LTM growth to 23%—above the 20% target. Two quarters into FY27, the company needs to show LTM momentum holding at 20%+ by Q2-end to justify the guidance. Product launches (eMACH.ai Lending, MSOCK, Credit Union Solution Suite, AI Awards recognition in September) and partnership announcements (5+ banking deals since July) suggest deal flow is strong. The question is timing of revenue recognition: many of these deals are announced but may take 1-2 quarters to move through the contract/deployment cycle. If Q2 sees these convert to ASP/expansion revenue, the story holds. If they defer to H2, the LTM rate may dip below 20% briefly, risking Street perception of a slowdown.
What the Street Says
1 · Deal Flow & Product Momentum (Positive)
5+ customer announcements in Q2: Jameel Finance Egypt (Oct 22), Cargills Bank Sri Lanka (Sep 23), UAE corporate banking deal (Jul 23), 3 NBFC eMACH.ai Custody wins (Jul 13), Credit Union Solution Suite (Jul 20), MSOCK launch (Sep 8). These validate market traction but do not guarantee Q2 revenue booking. Watch for management commentary on deal stage/ramp timing.
2 · FII Selling Pressure (Caution)
FII ownership fell from 23.51% (Q1 FY27) to 25.57% (Q4 FY26 prior); latest filing shows QoQ decline of 206bps. Coupled with the stock's 54% loss from ATH, this suggests either a macro IT sell-off or company-specific concern (margin pressure, deal-cycle lengthening). Management must address confidence on FY27 guide on the call.
3 · Insider/Promoter Activity
Arun Jain HUF shareholding disclosures in Sep (9/16, 9/22) suggest activity; Franklin Templeton sold 124,710 shares (Oct 15, -0.089% of cap). No major red flag, but watch for further large exits post-result.
4 · Board Meeting & Result Intimation
Board meeting scheduled Oct 30, 2026, to approve unaudited Q2 FY27 financials. Routine for result announcement; no new info, but confirms timing for earnings call post-market.
5 · Trading Window & Compliance
Trading window closure announced Sep 25 for Q3 results (effective Oct 1, closing 48 hours post-announcement). Routine governance; no risk signal.
Intellect Design Arena enters Q2 FY27 results on a pivot: the stock is down 54% from its January ATH, FII flows have turned negative, yet the company's AI-platform deal funnel and licensing revenue base remain solid. The Street consensus (Buy, ₹958–₹969 target) prices in a 50% recovery, which relies on the company maintaining 20%+ LTM growth and 23%+ EBITDA margins through FY27-28. Q2 results will be the acid test.
Three things to watch: (1) Revenue & margin: Does Q2 deliver ₹880–900 Cr with 23–24% EBITDA margin, keeping LTM growth ≥20%? (2) Licensing growth: Is Q1's 17% YoY licensing growth sustained or slowing, signaling either maturity or deal-stage delays? (3) FY27–28 guidance confidence: Does management reaffirm 20% LTM growth and the ₹4,000 Cr/₹1,000 Cr EBITDA targets by FY28, or hedge? A confident reaffirmation + steady execution talk could spark a near-term re-rating amid the oversold valuation.